The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...
Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...
The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to more than $13 billion, ...
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of ...
Eli Lilly is considering testing its blockbuster weight-loss drugs in people who are not overweight but are at risk of weight ...
It's the largest Print with a Purpose collection ever from the Palm Beach brand, to benefit an organization with strong ties ...
Lilly VandenBosch is in the process of becoming a nurse practitioner after living through a childhood battling the rare blood ...
Eli Lilly & Co. is pouring $4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback